Taisho Pharmaceutical Holdings Co Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:Taisho Pharmaceutical Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1975
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Taisho Pharmaceutical Holdings Co Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Taisho Pharmaceutical Holdings Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Taisho Pharmaceutical Holdings Co Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Taisho Pharmaceutical Holdings Co Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Taisho Pharmaceutical Holdings Co Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Taisho Pharmaceutical Holdings Co Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Taisho Pharmaceutical Holdings Co Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for Taisho Pharmaceutical Holdings Co Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Taisho Pharmaceutical Holdings Co Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 32
Corporate Venturing – Deal reports 32
PARTNERSHIP 35
Partnership – Overview 35
Partnership – Deal reports 36
DIVESTMENTS 62
Divestments – Overview 62
Divestments – Deal reports 63
APPENDIX 69
Contact Us 69
About MarketLine Financial Deals Database 69
Deal Definition and Methodology 71
About MarketLine 78

List of Tables
Table 1: Taisho Pharmaceutical Holdings Co Ltd M&A volume and value trend (2014-YTD2018)
Table 2: Taisho Pharmaceutical Holdings Co Ltd M&A activity by geography (2014-YTD2018)
Table 3: Taisho Pharmaceutical Holdings Co Ltd partnership volume and value trend (2014-YTD2018)
Table 4: Taisho Pharmaceutical Holdings Co Ltd partnership trend by key deal type (2014-YTD2018)
Table 5: Taisho Pharmaceutical Holdings Co Ltd divestments volume and value trend (2014-YTD2018)
Table 6: Taisho Pharmaceutical Holdings Co Ltd divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Taisho Pharmaceutical Holdings Co Ltd M&A volume and value trend (2014-YTD2018)
Figure 2: Taisho Pharmaceutical Holdings Co Ltd M&A activity by geography (2014-YTD2018)
Figure 3: Taisho Pharmaceutical Holdings Co Ltd partnership volume and value trend (2014-YTD2018)
Figure 4: Taisho Pharmaceutical Holdings Co Ltd partnership trend by key deal type (2014-YTD2018)
Figure 5: Taisho Pharmaceutical Holdings Co Ltd divestments volume and value trend (2014-YTD2018)
Figure 6: Taisho Pharmaceutical Holdings Co Ltd divestments by geography (2014-YTD2018)

★海外企業調査レポート[Taisho Pharmaceutical Holdings Co Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TomTec Imaging Systems GmbH-医療機器分野:企業M&A・提携分析
    Summary TomTec Imaging Systems GmbH (TomTec), formerly TomTec Tomographic Technologies GmbH is a medical device company that offers medical imaging and information management solutions. The company's products comprise image-arena platform, tomtec-arena, reporting, web-solution, IT integration, 2D ec …
  • IDT Corporation:企業の戦略・SWOT・財務情報
    IDT Corporation - Strategy, SWOT and Corporate Finance Report Summary IDT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • LIG Nex1 Co Ltd:企業の戦略・SWOT・財務分析
    LIG Nex1 Co Ltd - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Dataprep Holdings Berhad (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Berhad (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Aeroflot Oao
    Aeroflot Oao - Strategy, SWOT and Corporate Finance Report Summary Aeroflot Oao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Bel Fuse Inc. (BELFA):企業の財務・戦略的SWOT分析
    Bel Fuse Inc. (BELFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tokuyama Corp (4043)
    Tokuyama Corp (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Modern India Ltd:企業の戦略・SWOT・財務情報
    Modern India Ltd - Strategy, SWOT and Corporate Finance Report Summary Modern India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ogeda SA-製薬・医療分野:企業M&A・提携分析
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA is a biotechnology company that develops small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treats hormone-dependent pathologies in women's health. It also develops drugs to treat neurodegenerativ …
  • Hansgrohe SE:企業の戦略・SWOT・財務情報
    Hansgrohe SE - Strategy, SWOT and Corporate Finance Report Summary Hansgrohe SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PharmaLundensis AB:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務情報
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Enerjisa Enerji Uretim AS:電力:M&Aディール及び事業提携情報
    Summary Enerjisa Enerji Uretim A.S. (Enerjisa Enerji), a subsidiary of Enerjisa Enerji A.S, is an energy utility. The company generates electricity from natural gas, lignite coal, hydro, and wind sources. It owns and operates wind plants such as Canakkale in Mahmudiye, Dagpazari in Mut, and Balikesi …
  • Costcutter Supermarkets Group Ltd:企業の戦略・SWOT・財務分析
    Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Rich Pharmaceuticals Inc (RCHA):企業の財務・戦略的SWOT分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • Fiesta Mart LLC:企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Inivata Ltd:企業の製品パイプライン分析2018
    Summary Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in …
  • BCE Inc.:企業の戦略・SWOT・財務情報
    BCE Inc. - Strategy, SWOT and Corporate Finance Report Summary BCE Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆